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Background: Patients (pts) with fibromuscular dysplasia (FMD) present with aneurysm and dissection and may have features concerning for an 
underlying connective tissue disorder (CTD). The yield of genetic testing for vascular CTDs among FMD pts has not been determined. 
Methods: We present clinical data and genetic testing results for consecutive patients with confirmed FMD at a tertiary care center. 
Results: 197 FMD pts were identified. Mean age at diagnosis was 48.6 + 13.8 years; 93.4% were female. Genetic testing was performed in 16.8% 
of pts and 13.7% underwent genetic counseling but were not tested. Characteristics of pts referred for genetic testing vs. those not tested are shown 
below. Among pts who underwent genetic testing, 78.8% (26/33) were tested for TGFBR1 and TGFBR2 mutations, 72.7% (24/33) COL3A1, 6.1% 
(2/33) FBN1, and 21.2% (7/33) ACTA2. Two pts (8.3%, 2/24) tested for TGFBR1 and TGFBR2 were found to have point mutations in the TGFBR1 gene 
(c.611 C>T, p.Thr204lle and c.1285T>C, p.Tyr429His). Both had medial type FMD, a history of multi-vessel dissection, ectasia or aneurysm of the 
ascending aorta, and a family history of sudden death. There were no mutations identified in TGFBR2, COL3A1, FBN1, or ACTA2. 
Conclusions: The yield of genetic testing for known vascular CTDs was low in a high-risk subset of FMD pts. However, two pts with similar 
phenotype had previously unreported and distinct point mutations in the TGFBR1 gene, a finding which merits further investigation. 
Clinical Feature No Genetic Testing Done (N=164)
Genetic Testing Done
(N=33)
X2 P-value
Prior Arterial or Aortic Dissection 19.0% 63.6% <0.001
Aortic Aneurysm 1.8% 9.1% 0.027
Non Aortic Arterial Aneurysm 13.5% 24.2% 0.118
Exam Findings Consistent with CTD 17.8% 51.5% <0.001
Family History of FMD 8.1% 9.1% NS
Family History of Dissection 3.1% 6.1% NS
Family History of Aneurysm 23.6% 39.4% 0.06
Family History of Sudden Death 24.8% 42.4% 0.040
Family History of Stroke 55.9% 63.6% 0.413
